Advair HFA (Fluticasone Propionate and Salmeterol) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 22, 2016 Category: Drugs & Pharmacology Source Type: news
Flovent Diskus (Fluticasone Propionate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 10, 2016 Category: Drugs & Pharmacology Source Type: news
Cutivate Ointment (Fluticasone Propionate Ointment) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 31, 2016 Category: Drugs & Pharmacology Source Type: news
Flovent HFA (Fluticasone Propionate HFA) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 26, 2016 Category: Drugs & Pharmacology Source Type: news
Experience Journal: Asthma
Asthma is the most common chronic medical condition in the U.S., affecting nearly 10 percent of the population. The rate can be even higher in children; some Boston public schools report rates as high as 16 percent among students.
Children growing up with asthma often face difficulty breathing, and they may feel isolated from their peers. While this condition can be disruptive to a child’s life, it can be well controlled with proper medical care.
The Asthma Experience Journal, created by the Boston Children’s Hospital Department of Psychiatry and the Allergy and Asthma Program, includes stories and personal experi...
Source: Thrive, Children's Hospital Boston - June 15, 2016 Category: Pediatrics Authors: Erin Horan Tags: Diseases & Conditions asthma Experience Journal Source Type: news
Advair Diskus (Fluticasone Propionate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 23, 2016 Category: Drugs & Pharmacology Source Type: news
New Sandoz patient-centric inhaler now available to treat adults with COPD
Novel inhaler approved for adults with chronic obstructive pulmonary disease (COPD) (Source: Pharmacy Europe)
Source: Pharmacy Europe - November 24, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Practical therapeutics Respiratory Patient care AirFluSal copd fluticasone propionate Forspiro inhaler Latest News salmeterol Seretide Accuhaler treatment adherence Source Type: news
fluticasone propionate (Cutivate)
Title: fluticasone propionate (Cutivate)Category: MedicationsCreated: 3/2/2005 12:00:00 AMLast Editorial Review: 9/15/2015 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - September 15, 2015 Category: Dermatology Source Type: news
Dissolvable tablets don’t work for people with severe allergies to grass pollen
It’s summertime and—if you’re in Eugene, Oregon—the livin’ is sneezy. Eugene is the nation’s top spot for allergies this week according to IMS Health, a health information company that provides allergy alerts for cities across the nation. Eugene residents can blame their runny noses and itchy eyes on the city’s abundant grasses, which are currently spewing high levels of pollen into the air.
Eugene is just the tip of the allergy iceberg. If you live near a patch of green, you routinely inhale pollen. You’re in good company if your body reacts to it. More than 50 million Americans hav...
Source: New Harvard Health Information - July 2, 2015 Category: Consumer Health News Authors: Beverly Merz Tags: Asthma and Allergies dissolvable tablets grass pollen allergies Source Type: news
Adding a LAMA to Salmeterol/Fluticasone Improves COPD Lung FunctionAdding a LAMA to Salmeterol/Fluticasone Improves COPD Lung Function
Adding a once-a-day long-acting muscarinic antagonist (LAMA) to salmeterol/fluticasone propionate (SAL/FP) improves outcomes in chronic obstructive pulmonary disease (COPD), according to a report from Australia and New Zealand. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 8, 2015 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news
azelastine hydrochloride and fluticasone propionate (Dymista)
Title: azelastine hydrochloride and fluticasone propionate (Dymista)Category: MedicationsCreated: 4/20/2015 12:00:00 AMLast Editorial Review: 4/20/2015 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - April 20, 2015 Category: Allergy & Immunology Source Type: news
Is A Specific Corticosteroid Better for Treatment of Asthma Than Another?
Discussion
Asthma is a chronic obstructive lung disease that affects many children and adults. There is a wide range of symptoms that people experience from occurring relatively rarely (ie intermittent asthma) to patients having daily symptoms of such intensity that they are life-threatening (ie chronic severe asthma). The goals of asthma management include patient education and medication management so patients have no or minimal symptoms, prevent exacerbations, have no activity restrictions, have normal pulmonary function tests, have no or minimal medication side effects and meet patient and family expectations. Well con...
Source: PediatricEducation.org - January 5, 2015 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023...
LifeScienceIndustryResearch.com adds “Flovent (Asthma) – Forecast and Market Analysis to 2023” to its store. Obtain sales forecast for Flovent from 2013-2023 in top eight countries (the US, France,...(PRWeb September 21, 2014)Read the full story at http://www.prweb.com/releases/flovent-asthma-market/forecast-analysis-to-2023/prweb12184430.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 21, 2014 Category: Pharmaceuticals Source Type: news
Mundipharma reports Phase III flutiform trial results in paediatric asthma
Mundipharma has reported results from a randomised, multicentre, Phase III trial of flutiform, a combination of fluticasone propionate and formoterol in a single pressurised metered dose inhaler, to treat paediatric asthma. (Source: Drug Development Technology)
Source: Drug Development Technology - September 8, 2014 Category: Pharmaceuticals Source Type: news
